key: cord-0735444-qwso151q authors: Abdel Hafez, Sara Mohamed Naguib title: Can Covid-19 attack our nervous system? date: 2021-07-26 journal: J Chem Neuroanat DOI: 10.1016/j.jchemneu.2021.102006 sha: 86dac8ae6b3042bf7bdc740fb65409b1333bae1f doc_id: 735444 cord_uid: qwso151q Nowadays, Covid-19 is considered a serious health problem worldwide. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID-19). It is well known that the Corona Virus attacks mainly the respiratory system. Meanwhile, it has been established that coronavirus infection can extend beyond the respiratory system and unfortunately, can also affect our nervous system. Multiple neurological symptoms and signs had been documented during and post covid conditions. This virus gets access to the central nervous system (CNS) via the bloodstream leading to infect the endothelial lining cells. Also, it was reported that the virus can enter the peripheral nervous system via retrograde neuronal routes. The virus could be internalized in nerve synapses through endocytosis, transported retrogradely, and spread trans-synoptically to other brain regions. This minireview highlights the possible routes by which SARS-CoV-2 can invade the central nervous system (CNS) and its pathophysiology and manifestation. The emergence of SARS-CoV-2, the agent of novel coronavirus 2019 , has kept the globe in disquiets due to its severe life-threatening conditions (Achar and Ghosh, 2020; Mahalaxmi et al., 2021) . This shattering disease of 2019 (COVID-19) is a pandemic infectious disease caused by SARS-CoV-2 (Organization, 2020) . The first cases of COVID-19 were previously documented in December 2019 in Wuhan City, Hubei Province of China (Achar and Ghosh, 2020). After then, SARS-CoV-2 rapidly spread to over two hundred countries and territories (Rose-Redwood et al., 2020). Furthermore, the WHO reported COVID-19 as a global pandemic disease (Cucinotta and Vanelli, 2020). As of September 4, 2020, approximately twenty-six million cases of had been discovered, leading to ∼860,000 deaths worldwide (Cucinotta and Vanelli, 2020). SARS-CoV-2 is well known as a human coronavirus; an enveloped, positive-sensed, ssRNA virus characterized by its crown-like shape (Ye et al., 2020) . Even coronavirus (CoV) species are known as human pathogens; the epidemic viruses SARS-CoV, SARS-CoV-2, and MERS-CoV and those J o u r n a l P r e -p r o o f continuously circulating in human populations since initial isolation: HCoV-OC43, HCoV-229E, HCoV-HKU1, and HCoV-NL63. All lead to human central nervous system (CNS) dysfunction . In infants and young children, the most common CNS phenomena are febrile seizures; in adults, non-focal abnormalities may be either neurologic or constitutional (Morgello, 2020; Ye et al., 2020). Symptoms of COVID-19 range from mild to severe symptoms. Mild symptoms of COVID-19 including fever, chills, cough, dyspnea, fatigue, body aches, headache, loss of taste or smell, sore throat, congestion, nausea, and/or vomiting after two weeks of exposure to this virus (Ye et al., 2020). Severe signs from COVID-19 are in the form of pneumonia, acute respiratory distress syndrome, and sepsis (Jindal et al., 2020) . It has been well-established that people who are more susceptible to severe illness include those aged people (SMN, 2020). However, individuals of all ages are at a higher risk for severe illness if they suffer from any medical diseases or suffer from any comorbidities such as chronic lung, kidney, or liver disease, moderate to severe asthma, severe heart conditions, diabetes, severe obesity, and conditions that cause immunodeficiency (Thomé et al., 2020). It has been established that SARS-CoV-2 invades human cells through interaction with the human angiotensin-converting enzyme 2 (ACE2) receptor (Thomé et al., 2020) . This mechanism is detailed in the section "Mechanism of Viral Invasion: ACE2 Receptor". As COVID-19 is primarily a respiratory disease, high levels of ACE2 have been observed in pulmonary type II alveolar cells and respiratory epithelial cells. While, ACE2 expression is not limited to the respiratory tract but extended to other areas that as myocardial cells, ileal and esophageal epithelial cells, renal proximal tubule cells, and bladder urothelial cells Currently, exceptionally, mammalian coronaviruses are members of the alpha and beta genesis. The global distribution of coronavirus species is "driven" by bat populations, which constitute the major viral reservoir. In regions of the world where bats are highly diverse, as in portions of Asia and Africa, host switching is the dominant mechanism of viral evolution (Anthony et al., 2017) . Thus, zoonotic transmission to man a had higher likelihood in these geographic areas, like host switching is its predicate. There are currently 7 known human coronaviruses; almost all have zoonotic origins or are known to circulate in animals (Anthony et al., 2017). Animal surveillance had been suggested as a useful technique in combatting epidemic viruses as, both SARS-CoV and SARS-CoV-2 could infect as well replicate in domestic cats, with transmission from infected to uninfected cats occurring through respiratory droplets (Anthony et al., 2017) . As these common J o u r n a l P r e -p r o o f pets may be in the community as well as in close contact with their owners at home, they may conceivably provide an adjunctive mechanism for virus tracking. SARS-CoV-2 is a highly pathogenic coronavirus that had led to ongoing worldwide pandemic disease (Sharma et al., 2020) . One of the earliest symptoms reported in covid is loss of smell. It was reported that the virus could access to the central nervous system through the bloodstream with subsequently leads to endothelial cell infection. Additionally, the virus can enter the peripheral nervous system through retrograde neuronal routes (Abdullahi et al., 2020) . This virus may internalize into the nerve terminals via endocytosis, transported retrogradely, and widely spread trans-synoptically to other brain areas (Iadecola et al., 2020) . Angiotensin-converting enzyme -2 receptor; was observed in the nasal mucosal lining; is attacked by the virus. The presence of these receptors in the tissues of the central nervous system is hypothesized to be the reason that the virus subsequently leads to neurological symptoms and signs (Moreno et al., 2004) . After the virus goes to the cerebral circulation, its protein S protein interacts with the capillary endothelium ACE-2 receptors. After then, the virus buds from the capillary endothelium leading to the widespread of the virus in multiple areas of the brain and brainstem through the Virchow-Robin spaces surrounding both the arterioles and venules (Iadecola et al., 2020) . Cytokine It was decomented that the major clinical manifestations of SARS-CoV-2 infection are respiratory due to pulmonary complications. Symptoms can be mild, including fever, headache, cough, dyspnea, and myalgia; or severe, such as acute respiratory distress syndrome (ARDS), which sometimes develops about 1 week into the illness and may result in death. CNS complications of COVID-19 infection have not been systematically investigated or analyzed (Khateb et al., 2020) . Additional neurological signs, documented in patients with severe SARS-CoV-2 with ARDS include myalgia (Munhoz et al., 2020) , diffuse corticospinal tract signs with enhanced tendon reflexes and ankle clonus, and dysexecutive syndrome. Other signs, imaging findings included perfusion abnormalities in all the patients, leptomeningeal enhancement in most of them, and cerebral ischemia in about 23%. Meanwhile, these results should be interpreted cautiously, as they could represent, at least in part, different effects of the critical illness state, regardless of the SARS-CoV-2 etiology (Khateb et al., 2020) . This minireview highlights the possible routes by which SARS-CoV-2 can invade the central nervous system (CNS) and its pathophysiology and manifestation. This virus gets access to the central nervous system (CNS) via the bloodstream leading to infect the endothelial lining cells. Also, it was reported that the virus can enter the peripheral nervous system via retrograde neuronal routes. Neurological and musculoskeletal features of COVID-19: a systematic review and meta-analysis COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance Overview of lethal human coronaviruses Impact of chronic exercise on counteracting chronic stress-induced functional and morphological pancreatic changes in male albino rats Sex differences impact the pancreatic response to chronic immobilization stress in rats Effects of COVID-19 on the nervous system The prevention and management of COVID-19: seeking a practical and timely solution Coronaviruses and central nervous system manifestations COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases Neurologic manifestations of hospitalized patients with coronavirus disease Immunolocalization of peroxisome proliferatoractivated receptors and retinoid X receptors in the adult rat CNS Coronaviruses and the central nervous system Neurological complications in patients with SARS-CoV-2 infection: a systematic review Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings Coronaviridae: the viruses and their replication. Fields virologyemerging viruses 1 Geographies of the COVID-19 pandemic Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies Glucose-6-phosphate dehydrogenase deficiency enhances Covid-19 infection in elderly people The Histochemistry and Cell Biology omnium-gatherum: the year 2015 in review Differences in the prevalence of risk factors for severe COVID-19 across regions of São Paulo City 2020. Neurological manifestations and implications of COVID-19 pandemic. Therapeutic advances in neurological disorders 13 Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study Emerging Infections of CNS: Avian Influenza A Virus, R ift V alley Fever Virus and Human Parechovirus Zoonotic origins of human coronaviruses